68 Ga FAPI-46 Fibroblast Activation Protein Inhibitor Uptake in Graves’ Ophthalmopathy
Indian Journal of Nuclear Medicine · 10.08.2026 · 1-3
DOI: 10.25259/ijnm_126_2026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Nuclear Medicine, online erschienen am 10.08.2026. Verfasst von Mohammad Umar und 5 weiteren Autor:innen. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Fibroblast activation protein inhibitor (FAPI) PET/CT has emerged as a novel imaging technique for fibroblast-driven pathology. Orbital fibroblast activation is central to the pathogenesis of Graves’ ophthalmopathy (GO), making fibroblast activation protein (FAP) a mechanistically appropriate molecular target. We report a case of a 59-year-old female with steroid-refractory active GO (clinical activity score 6/7) who underwent 68 Ga 46 FAPI PET/CT, which demonstrated tracer accumulation in bilateral extraocular muscles with a topographic distribution consistent with known disease anatomy. Imaging findings correlated with high disease activity despite immunosuppressive therapy, suggesting
Zitieren
APA
Umar, M., Damle, N. A., Bishnoi, K., Agrawal, S., Meel, R., & Tyagi, A. (2026). 68 Ga FAPI-46 Fibroblast Activation Protein Inhibitor Uptake in Graves’ Ophthalmopathy. Indian Journal of Nuclear Medicine, 0, 1-3. https://doi.org/10.25259/ijnm_126_2026
Vancouver
Umar M, Damle NA, Bishnoi K, Agrawal S, Meel R, Tyagi A. 68 Ga FAPI-46 Fibroblast Activation Protein Inhibitor Uptake in Graves’ Ophthalmopathy. Indian Journal of Nuclear Medicine. 2026;0:1-3. doi:10.25259/ijnm_126_2026
BibTeX
@article{Umar2026,
author = {Umar, Mohammad and Damle, Nishikant Avinash and Bishnoi, Komal and Agrawal, Sahil and Meel, Rachna and Tyagi, Apoorva},
title = {68 Ga FAPI-46 Fibroblast Activation Protein Inhibitor Uptake in Graves’ Ophthalmopathy},
journal = {Indian Journal of Nuclear Medicine},
year = {2026},
volume = {0},
pages = {1--3},
doi = {10.25259/ijnm_126_2026}
}
EUVIMED